Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Posluma. Always confirm against the full prescribing information.
8 interactions
Apalutamide
Apalutamide may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Bicalutamide
Bicalutamide may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Clascoterone
Clascoterone may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Darolutamide
Darolutamide may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Enzalutamide
Enzalutamide may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Flutamide
Flutamide may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Nilutamide
Nilutamide may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Level 1 evidence
Relugolix
Relugolix may decrease effectiveness of Flotufolastat F-18 as a diagnostic agent.
Posluma (Flotufolastat F-18) has 8 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Posluma (Flotufolastat F-18) has 0 major, 0 moderate, and 8 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Posluma. Always confirm against the full prescribing information.